Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data https://t.co/Xjj2svjEVQ https://t.co/NwGe4P82k3
2,170 followers
17 followers
Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data https://t.co/fAtSVOOgww https://t.co/wrsnMbkrEI
721 followers
#HealthEconJA Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data https://t.co/Pt0oMuFGS0